NICE Analyst Ratings
NICE Analyst Ratings
NICE 分析师评级
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/05/2023 | 33.83% | Oppenheimer | $250 → $225 | Maintains | Outperform |
| 09/29/2023 | 13.01% | DA Davidson | → $190 | Initiates Coverage On | → Neutral |
| 08/18/2023 | 41.57% | RBC Capital | → $238 | Reiterates | Outperform → Outperform |
| 08/18/2023 | 104.02% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform |
| 08/15/2023 | 101.05% | Citigroup | $278 → $338 | Maintains | Buy |
| 07/26/2023 | — | William Blair | Initiates Coverage On | → Outperform | |
| 06/14/2023 | 104.02% | JMP Securities | → $343 | Reiterates | Market Outperform → Market Outperform |
| 06/07/2023 | 41.57% | RBC Capital | → $238 | Reiterates | Outperform → Outperform |
| 05/31/2023 | 45.13% | Mizuho | → $244 | Initiates Coverage On | → Buy |
| 05/12/2023 | 36.81% | Wedbush | $250 → $230 | Maintains | Outperform |
| 05/12/2023 | 39.78% | Jefferies | $260 → $235 | Maintains | Buy |
| 05/10/2023 | 65.36% | Citigroup | $277 → $278 | Maintains | Buy |
| 02/24/2023 | 64.76% | Citigroup | $301 → $277 | Maintains | Buy |
| 01/17/2023 | 35.02% | Piper Sandler | $222 → $227 | Upgrades | Neutral → Overweight |
| 11/11/2022 | 33.83% | Morgan Stanley | $215 → $225 | Maintains | Equal-Weight |
| 11/11/2022 | 54.65% | Citigroup | $254 → $260 | Maintains | Buy |
| 11/01/2022 | 51.08% | Citigroup | $275 → $254 | Maintains | Buy |
| 10/11/2022 | 27.88% | Morgan Stanley | $235 → $215 | Maintains | Equal-Weight |
| 08/25/2022 | 40.38% | Piper Sandler | → $236 | Initiates Coverage On | → Neutral |
| 08/22/2022 | 48.7% | Wedbush | $220 → $250 | Maintains | Outperform |
| 08/19/2022 | 63.57% | JP Morgan | $260 → $275 | Maintains | Overweight |
| 08/19/2022 | 57.63% | RBC Capital | $240 → $265 | Maintains | Outperform |
| 07/26/2022 | 68.33% | Barclays | $356 → $283 | Maintains | Overweight |
| 07/14/2022 | 39.78% | Morgan Stanley | $260 → $235 | Maintains | Equal-Weight |
| 05/13/2022 | 42.76% | RBC Capital | $365 → $240 | Maintains | Outperform |
| 02/22/2022 | 54.65% | Morgan Stanley | $315 → $260 | Maintains | Equal-Weight |
| 02/18/2022 | 90.34% | Jefferies | $350 → $320 | Maintains | Buy |
| 12/16/2021 | 87.37% | Morgan Stanley | → $315 | Downgrades | Overweight → Equal-Weight |
| 09/09/2021 | 104.02% | JMP Securities | $302 → $343 | Maintains | Market Outperform |
| 08/06/2021 | 93.31% | RBC Capital | $300 → $325 | Maintains | Outperform |
| 07/07/2021 | 78.44% | RBC Capital | → $300 | Upgrades | Sector Perform → Outperform |
| 06/09/2021 | 54.65% | JP Morgan | → $260 | Upgrades | Neutral → Overweight |
| 05/26/2021 | 72.5% | Morgan Stanley | $338 → $290 | Maintains | Overweight |
| 05/14/2021 | 76.06% | Citigroup | $312 → $296 | Maintains | Buy |
| 02/22/2021 | 101.05% | Morgan Stanley | $334 → $338 | Maintains | Overweight |
| 02/19/2021 | 101.05% | Morgan Stanley | $334 → $338 | Maintains | Overweight |
| 02/19/2021 | 69.52% | Wedbush | $275 → $285 | Maintains | Outperform |
| 02/11/2021 | 72.5% | Oppenheimer | → $290 | Assumes | → Outperform |
| 01/29/2021 | 96.29% | Barclays | $246 → $330 | Upgrades | Equal-Weight → Overweight |
| 12/17/2020 | 98.67% | Morgan Stanley | $230 → $334 | Upgrades | Equal-Weight → Overweight |
| 11/13/2020 | 36.81% | Morgan Stanley | $212 → $230 | Maintains | Equal-Weight |
| 11/13/2020 | 72.5% | Rosenblatt | $265 → $290 | Reiterates | → Buy |
| 11/13/2020 | 63.57% | Wedbush | $250 → $275 | Maintains | Outperform |
| 11/03/2020 | 66.55% | B of A Securities | → $280 | Initiates Coverage On | → Buy |
| 10/22/2020 | 57.63% | Rosenblatt | $260 → $265 | Maintains | Buy |
| 08/07/2020 | 26.1% | Morgan Stanley | $156 → $212 | Maintains | Equal-Weight |
| 06/26/2020 | 2.31% | JP Morgan | → $172 | Downgrades | Neutral → Underweight |
| 06/18/2020 | 18.96% | Oppenheimer | $180 → $200 | Maintains | Outperform |
| 05/15/2020 | -7.21% | Morgan Stanley | $144 → $156 | Maintains | Equal-Weight |
| 05/11/2020 | -14.35% | Morgan Stanley | $133 → $144 | Maintains | Equal-Weight |
| 03/25/2020 | -20.89% | Morgan Stanley | $173 → $133 | Maintains | Equal-Weight |
| 02/14/2020 | 2.9% | Morgan Stanley | $160 → $173 | Maintains | Equal-Weight |
| 02/14/2020 | 18.96% | Wedbush | $185 → $200 | Maintains | Outperform |
| 02/14/2020 | 15.99% | Rosenblatt | $187 → $195 | Maintains | Buy |
| 02/14/2020 | 14.8% | Citigroup | $156 → $193 | Maintains | Neutral |
| 01/27/2020 | -3.05% | JP Morgan | → $163 | Downgrades | Overweight → Neutral |
| 11/27/2019 | 1.12% | Oppenheimer | $166 → $170 | Maintains | Outperform |
| 11/18/2019 | -10.78% | Morgan Stanley | $140 → $150 | Maintains | Equal-Weight |
| 11/15/2019 | 1.12% | Wedbush | $165 → $170 | Maintains | Outperform |
| 09/04/2019 | 11.23% | Rosenblatt | → $187 | Initiates Coverage On | → Buy |
| 08/09/2019 | 10.04% | JMP Securities | $164 → $185 | Maintains | Market Outperform |
| 05/17/2019 | -18.51% | Citigroup | $117 → $137 | Maintains | Neutral |
| 05/17/2019 | -2.45% | JMP Securities | $140 → $164 | Maintains | Market Outperform |
| 05/17/2019 | -23.86% | Morgan Stanley | $117 → $128 | Maintains | Equal-Weight |
| 04/24/2019 | -10.78% | Barclays | $124 → $150 | Maintains | Equal-Weight |
| 04/18/2019 | -10.78% | JP Morgan | $125 → $150 | Upgrades | Neutral → Overweight |
| 04/17/2019 | -25.65% | DA Davidson | $110 → $125 | Maintains | Neutral |
| 04/17/2019 | -13.75% | Oppenheimer | $125 → $145 | Maintains | Outperform |
| 01/07/2019 | -30.41% | Morgan Stanley | $107 → $117 | Maintains | Equal-Weight |
| 10/19/2018 | -22.67% | Wedbush | → $130 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/05/2023 | 33.83% | 奥本海默 | $250→$225 | 维护 | 跑赢大盘 |
| 09/29/2023 | 13.01% | 达·戴维森 | →$190 | 开始承保 | →中性 |
| 2023年08月18日 | 41.57% | 加拿大皇家银行资本 | →$238 | 重申 | 跑赢→跑赢大盘 |
| 2023年08月18日 | 104.02% | JMP证券 | →$343 | 重申 | 市场表现优于→市场表现 |
| 2023年08月15日 | 101.05% | 花旗集团 | $278→$338 | 维护 | 买 |
| 07/26/2023 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 2023/06/14 | 104.02% | JMP证券 | →$343 | 重申 | 市场表现优于→市场表现 |
| 06/07/2023 | 41.57% | 加拿大皇家银行资本 | →$238 | 重申 | 跑赢→跑赢大盘 |
| 2023年05月31日 | 45.13% | 瑞穗 | →$244 | 开始承保 | →购买 |
| 2023年05月12日 | 36.81% | 韦德布什 | $250→$230 | 维护 | 跑赢大盘 |
| 2023年05月12日 | 39.78% | 杰富瑞 | $260→$235 | 维护 | 买 |
| 2023年05月10日 | 65.36% | 花旗集团 | $277→$278 | 维护 | 买 |
| 02/24/2023 | 64.76% | 花旗集团 | $301→$277 | 维护 | 买 |
| 01/17/2023 | 35.02% | 派珀·桑德勒 | $222→$227 | 升级 | 中性→超重 |
| 2022年11月11日 | 33.83% | 摩根士丹利 | $215→$225 | 维护 | 等重 |
| 2022年11月11日 | 54.65% | 花旗集团 | $254→$260 | 维护 | 买 |
| 11/01/2022 | 51.08% | 花旗集团 | $275→$254 | 维护 | 买 |
| 2022年10月11日 | 27.88% | 摩根士丹利 | $235→$215 | 维护 | 等重 |
| 2022年08月25日 | 40.38% | 派珀·桑德勒 | →$236 | 开始承保 | →中性 |
| 2022/08/22 | 48.7% | 韦德布什 | $220→$250 | 维护 | 跑赢大盘 |
| 2022年08月19日 | 63.57% | 摩根大通 | $260→$275 | 维护 | 超重 |
| 2022年08月19日 | 57.63% | 加拿大皇家银行资本 | $240→$265 | 维护 | 跑赢大盘 |
| 07/26/2022 | 68.33% | 巴克莱 | $356→$283 | 维护 | 超重 |
| 07/14/2022 | 39.78% | 摩根士丹利 | $260→$235 | 维护 | 等重 |
| 2022年05月13日 | 42.76% | 加拿大皇家银行资本 | $365→$240 | 维护 | 跑赢大盘 |
| 02/22/2022 | 54.65% | 摩根士丹利 | $315→$260 | 维护 | 等重 |
| 02/18/2022 | 90.34% | 杰富瑞 | $350→$320 | 维护 | 买 |
| 12/16/2021 | 87.37% | 摩根士丹利 | →$315 | 评级下调 | 超重→等重 |
| 09/09/2021 | 104.02% | JMP证券 | $302→$343 | 维护 | 市场表现强于大盘 |
| 08/06/2021 | 93.31% | 加拿大皇家银行资本 | $300→$325 | 维护 | 跑赢大盘 |
| 07/07/2021 | 78.44% | 加拿大皇家银行资本 | →$300 | 升级 | 行业表现优于→ |
| 06/09/2021 | 54.65% | 摩根大通 | →$260 | 升级 | 中性→超重 |
| 2021/05/26 | 72.5% | 摩根士丹利 | $338→$290 | 维护 | 超重 |
| 2021/05/14 | 76.06% | 花旗集团 | $312→$296 | 维护 | 买 |
| 02/22/2021 | 101.05% | 摩根士丹利 | $334→$338 | 维护 | 超重 |
| 02/19/2021 | 101.05% | 摩根士丹利 | $334→$338 | 维护 | 超重 |
| 02/19/2021 | 69.52% | 韦德布什 | $275→$285 | 维护 | 跑赢大盘 |
| 02/11/2021 | 72.5% | 奥本海默 | →$290 | 假设 | →跑赢大盘 |
| 2021/01/29 | 96.29% | 巴克莱 | $246→$330 | 升级 | 等重→超重 |
| 12/17/2020 | 98.67% | 摩根士丹利 | $230→$334 | 升级 | 等重→超重 |
| 11/13/2020 | 36.81% | 摩根士丹利 | $212→$230 | 维护 | 等重 |
| 11/13/2020 | 72.5% | 罗森布拉特 | $265→$290 | 重申 | →购买 |
| 11/13/2020 | 63.57% | 韦德布什 | $250→$275 | 维护 | 跑赢大盘 |
| 11/03/2020 | 66.55% | B of A证券 | →$280 | 开始承保 | →购买 |
| 10/22/2020 | 57.63% | 罗森布拉特 | $260→$265 | 维护 | 买 |
| 08/07/2020 | 26.1% | 摩根士丹利 | $156→$212 | 维护 | 等重 |
| 06/26/2020 | 2.31% | 摩根大通 | →$172 | 评级下调 | 中性→减持 |
| 06/18/2020 | 18.96% | 奥本海默 | $180→$200 | 维护 | 跑赢大盘 |
| 2020/05/15 | -7.21% | 摩根士丹利 | $144→$156 | 维护 | 等重 |
| 05/11/2020 | -14.35% | 摩根士丹利 | $133→$144 | 维护 | 等重 |
| 03/25/2020 | -20.89% | 摩根士丹利 | $173→$133 | 维护 | 等重 |
| 02/14/2020 | 2.9% | 摩根士丹利 | $160→$173 | 维护 | 等重 |
| 02/14/2020 | 18.96% | 韦德布什 | $185→$200 | 维护 | 跑赢大盘 |
| 02/14/2020 | 15.99% | 罗森布拉特 | $187→$195 | 维护 | 买 |
| 02/14/2020 | 14.8% | 花旗集团 | $156→$193 | 维护 | 中性 |
| 2020/01/27 | -3.05% | 摩根大通 | →$163 | 评级下调 | 超重→中性 |
| 2019年11月27日 | 1.12% | 奥本海默 | $166→$170 | 维护 | 跑赢大盘 |
| 2019年11月18日 | -10.78% | 摩根士丹利 | $140→$150 | 维护 | 等重 |
| 2019年11月15日 | 1.12% | 韦德布什 | $165→$170 | 维护 | 跑赢大盘 |
| 2019年09月04日 | 11.23% | 罗森布拉特 | →$187 | 开始承保 | →购买 |
| 2019年08月09日 | 10.04% | JMP证券 | $164→$185 | 维护 | 市场表现强于大盘 |
| 2019年05月17日 | -18.51% | 花旗集团 | $117→$137 | 维护 | 中性 |
| 2019年05月17日 | -2.45% | JMP证券 | $140→$164 | 维护 | 市场表现强于大盘 |
| 2019年05月17日 | -23.86% | 摩根士丹利 | $117→$128 | 维护 | 等重 |
| 2019年04月24日 | -10.78% | 巴克莱 | $124→$150 | 维护 | 等重 |
| 2019/04/18 | -10.78% | 摩根大通 | $125→$150 | 升级 | 中性→超重 |
| 2019/04/17 | -25.65% | 达·戴维森 | $110→$125 | 维护 | 中性 |
| 2019/04/17 | -13.75% | 奥本海默 | $125→$145 | 维护 | 跑赢大盘 |
| 2019年07月01日 | -30.41% | 摩根士丹利 | $107→$117 | 维护 | 等重 |
| 2018年10月19日 | -22.67% | 韦德布什 | →$130 | 开始承保 | →跑赢大盘 |
What is the target price for NICE (NICE)?
尼斯(NICE)的目标价格是多少？
The latest price target for NICE (NASDAQ: NICE) was reported by Oppenheimer on October 5, 2023. The analyst firm set a price target for $225.00 expecting NICE to rise to within 12 months (a possible 33.83% upside). 18 analyst firms have reported ratings in the last year.
奥本海默于2023年10月5日报道了NICE(纳斯达克：NICE)的最新目标价。这家分析公司将NICE的目标价定为225.00美元，预计NICE将在12个月内上涨至33.83%(可能上涨33.83%)。去年有18家分析公司公布了评级。
What is the most recent analyst rating for NICE (NICE)?
分析师对尼斯(NICE)的最新评级是多少？
The latest analyst rating for NICE (NASDAQ: NICE) was provided by Oppenheimer, and NICE maintained their outperform rating.
分析师对NICE(纳斯达克：NICE)的最新评级是由奥本海默提供的，NICE维持其表现优于大盘的评级。
When is the next analyst rating going to be posted or updated for NICE (NICE)?
NICE(NICE)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NICE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NICE was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与NICE的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。NICE的上一次评级是在2023年10月5日提交的，所以你应该预计下一次评级将在2024年10月5日左右的某个时候公布。
Is the Analyst Rating NICE (NICE) correct?
分析师的评级是不是很好？
While ratings are subjective and will change, the latest NICE (NICE) rating was a maintained with a price target of $250.00 to $225.00. The current price NICE (NICE) is trading at is $168.12, which is out of the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的NICE(NICE)评级维持不变，目标价在250.00美元至225.00美元之间。目前尼斯(NICE)的交易价格为168.12美元，超出了分析师的预测区间。